Search research articles
Contact Us
Filters
Showing results (111-120 of 174) with videos related to
Page
of 18
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN
|
September 9, 2021
Infection in Patients with Suspected Thrombotic Microangiopathy Based on Clinical Presentation
Benjamin Thoreau, Florent von Tokarski, Adeline Bauvois, et al.
Bone Marrow Transplantation
|
March 4, 2021
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial
Benoit Tessoulin, David Chiron, Catherine Thieblemont, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 14, 2019
Etiology and Outcomes of Thrombotic Microangiopathies
Guillaume Bayer, Florent von Tokarski, Benjamin Thoreau, et al.
Blood Advances
|
April 17, 2023
Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group
Yassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2011
Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants
Judith Trotman, Marion Fournier, Thierry Lamy, et al.
Haematologica
|
March 12, 2010
Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group
Rémy Gressin, Sylvie Caulet-Maugendre, Eric Deconinck, et al.
British Journal of Haematology
|
April 26, 2025
Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group
Charles Herbaux, Emmanuel Bachy, Reda Bouabdallah, et al.
Blood
|
October 29, 2008
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years
Emmanuel Gyan, Charles Foussard, Philippe Bertrand, et al.
Hematological Oncology
|
May 31, 2020
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group
Yannick Le Bris, Florence Magrangeas, Anne Moreau, et al.
Blood
|
December 14, 2011
Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes
Emilie Frisan, Julie Vandekerckhove, Aurélie de Thonel, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 174) with videos related to
Sort By:
Page
of 18
Clinical Journal of the American Society of Nephrology : CJASN
|
September 9, 2021
Infection in Patients with Suspected Thrombotic Microangiopathy Based on Clinical Presentation
Benjamin Thoreau, Florent von Tokarski, Adeline Bauvois, et al.
Bone Marrow Transplantation
|
March 4, 2021
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial
Benoit Tessoulin, David Chiron, Catherine Thieblemont, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 14, 2019
Etiology and Outcomes of Thrombotic Microangiopathies
Guillaume Bayer, Florent von Tokarski, Benjamin Thoreau, et al.
Blood Advances
|
April 17, 2023
Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group
Yassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2011
Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants
Judith Trotman, Marion Fournier, Thierry Lamy, et al.
Haematologica
|
March 12, 2010
Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group
Rémy Gressin, Sylvie Caulet-Maugendre, Eric Deconinck, et al.
British Journal of Haematology
|
April 26, 2025
Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group
Charles Herbaux, Emmanuel Bachy, Reda Bouabdallah, et al.
Blood
|
October 29, 2008
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years
Emmanuel Gyan, Charles Foussard, Philippe Bertrand, et al.
Hematological Oncology
|
May 31, 2020
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group
Yannick Le Bris, Florence Magrangeas, Anne Moreau, et al.
Blood
|
December 14, 2011
Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes
Emilie Frisan, Julie Vandekerckhove, Aurélie de Thonel, et al.
Page
of 18